The effects of Cordyceps sinensis phytoestrogen on estrogen deficiency-induced osteoporosis in Ovariectomized rats

BMC Complementary and Alternative Medicine

Volumn 14, Issue 1, 2014, Pages

  Zhang, Da wei ^a   Wang, Zhen lin ^c   Qi, Wei ^a,b   Zhao, Guang yue ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Surgery Department of 520th Hospital of PLA   (China)

^c No 113 Hospital of People's Liberation Army   (China)

Author keywords

Cordyceps sinensis; Estrogens; Isoflavones; Osteoporosis; Phytoestrogen

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; ESTRADIOL; FOLLITROPIN; GAMMA INTERFERON; HOMOCYSTEINE; LUTEINIZING HORMONE; OSTEOCALCIN; PHOSPHATE; PHYTOESTROGEN; TELOPEPTIDE; ACID PHOSPHATASE; BIOLOGICAL PRODUCT; BONE DENSITY CONSERVATION AGENT; ESTROGEN; ISOFLAVONE DERIVATIVE; PHOSPHORUS;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE STRUCTURE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTROGEN DEFICIENCY INDUCED OSTEOPOROSIS; FEMALE; FOLLITROPIN BLOOD LEVEL; HISTOPATHOLOGY; LUTEINIZING HORMONE BLOOD LEVEL; MICROSCOPY; NONHUMAN; OPHIOCORDYCEPS; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PHOSPHATE BLOOD LEVEL; RAT; UTERUS WEIGHT; ANIMAL; BLOOD; BONE DISEASES, METABOLIC; CHEMISTRY; CORDYCEPS; DEFICIENCY; DRUG EFFECTS; HUMAN; METABOLISM; PATHOLOGY; PHYTOTHERAPY; UTERUS; WISTAR RAT;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL PRODUCTS; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; COLLAGEN TYPE I; CORDYCEPS; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; INTERFERON-GAMMA; ISOFLAVONES; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; PHOSPHORUS; PHYTOESTROGENS; PHYTOTHERAPY; RATS; RATS, WISTAR; UTERUS;

EID: 84924289870     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-484     Document Type: Article

References (44)

1. Zhu JS, Halpern GM, Jones K: The scientific rediscovery of an ancient Chinese herbal medicine. Cordyceps sinensis. J Altern Complement Med 1998, 4:289-303. 10.1089/acm.1998.4.3-289
2. Kuo YC, Tsai WJ, Shiao MS, Chen CF, Lin CY: Cordyceps sinensis as an immunomodulatory agent. Am J Chin Med 1996, 24:111-125. 10.1142/S0192415X96000165
3. Yang LY, Chen A, Kuo YC, Lin CY: Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL lpr/lpr mice. J Lab Clin Med 1999, 134:492-500. 10.1016/S0022-2143(99)90171-3
4. Kuo YC, Tsai WJ, Wang JY, Chang SC, Lin CY, Shiao MS: Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis. Life Sci 2001, 68:1067-1082. 10.1016/S0024-3205(00)01011-0
5. Kuo YC, Lin CY, Tsai WJ, Wu CL, Chen CF, Shiao MS: Growth inhibitors against tumor cells in Cordyceps sinensis other than cordycepin and polysaccharides. Cancer Invest 1994, 12:611-615. 10.3109/07357909409023046
6. Bok JW, Lermer L, Chilton J, Klingeman HG, Towers GH: Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999, 51:891-898. 10.1016/S0031-9422(99)00128-4
7. Manabe N, Azuma Y, Sugimoto M, Uchio K, Miyamoto M, Taketomo N, Tsuchita H, Miyamoto H: Effects of the mycelial extract of cultured Cordyceps sinensis on in vivo hepatic energy metabolism and blood flow in dietary hypoferric anaemic mice. Br J Nutr 2000, 83:197-204.
8. Balon TW, Jasman AP, Zhu JS: A fermentation product of Cordyceps sinensis increases whole-body insulin sensitivity in rats. J Altern Complement Med 2002, 8:315-323.
9. Koh JH, Kim JM, Chang UJ, Suh HJ: Hypocholesterolemic effect of hot-water extract from mycelia of Cordyceps sinensis. Biol Pharm Bull 2003, 26:4-87.
10. Chiou WF, Chang PC, Chou CJ, Chen CF: Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis. Life Sci 2000, 66:1369-1376. 10.1016/S0024-3205(00)00445-8
11. Qi W, Yan YB, Wang PJ, Lei W: The Co-effect of Cordyceps sinensis and Strontium on Osteoporosis in Ovariectomized Osteopenic Rats. Biol Trace Elem Res 2010,141(1-3):216-223.
12. Messina MJ, Persky V, Setchell KD, Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994, 21:113-131. 10.1080/01635589409514310
13. Van der Schouw YT, de Kleijn MJ, Peeters PH, Grobbee DE: Phyto-oestrogens and cardiovascular disease risk. Nutr Metab Cardiovasc Dis 2000, 10:154-167.
14. Webb CM, Hayward CS, Mason MJ, Llsley CD, Collins P: Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease. Clin Sci (London) 2008, 115:353-359. 10.1042/CS20070443
15. Price KR, Fenwick GR: Naturally occurring oestrogens in foods-a review. Food Addit Contam 1985,2(2):73-106. 10.1080/02652038509373531
16. Setchell KD, Cassidy A: Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999,129(3):758S-767S.
17. Waldman TN: Menopause: when hormone replacement therapy is not an option. Part II. J Women Health 1998, 7:673-683. 10.1089/jwh.1998.7.673
18. Barnabei VM, Grady D, Stovall DW, Cauley JA, Lin F, Stuenkel CA, Stefanick ML, Pickar JH: Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002, 100:1209-1218. 10.1016/S0029-7844(02)02369-4
19. Choi JN, Kim J, Lee MY, Park DK, Hong YS, Lee CH: Metabolomics revealed novel isoflavones and optimal cultivation time of Cordyceps militaris fermentation. J Agric Food Chem 2010, 58:4258-4267. 10.1021/jf903822e
20. Weiss J, Taylor GR, Zimmermann F, Nebendahl K: Collection of Body Fluids. In Laboratory Rat Book. New York: Academic Press; 2000:485-510.
21. Changrani NR, Chonkar A, Adeghate E: Effects of streptozotocininduced type 1 diabetes mellitus on total protein concentrations and cation contents in the isolated pancreas, parotid, submandibular, and lacrimal glands of rats. Ann N Y Acad Sci 2006, 1084:503-519. 10.1196/annals.1372.019
22. Bessy OA, Lowry OH, Brock MJ: A method for the rapid determination of alkaline phosphatase with five cubic millimetres of serum. J Biol Chem 1946, 164:321-329.
23. Godkar P: Enzymes. In Textbook of Medical Laboratory Techniques, Ed. Mumbai, India: Bhalani Publishing House; 1994:149-167.
24. Repo MA, Bockman RS, Betts F, Boskey AL, Alcock NW, Warrell RP Jr: Effect of gallium on bone mineral properties. Calcif Tissue Int 1988,43(5):300-306. 10.1007/BF02556640
25. Cho PW, Fox JL, Higuchi WI, Pithayanukul P: Influence of dodecylamine hydrochloride adsorption on the dissolution kinetics of hydroxyapatite. In Adsorption on and surface chemistry of hydroxyapatite. Edited by: Misra DN. New York: Plenum Press; 1984:51-70.
26. Mueller M, Hobiger S, Jungbauer A: Red clover extract: a source for substances that activate peroxisome proliferator-activated receptor alpha and ameliorate the cytokine secretion profile of lipopolysaccharide-stimulated macrophages. Menopause 2010,17(2):379-387. 10.1097/gme.0b013e3181c94617
27. Mueller M, Jungbauer A: Red clover extract: a putative source for simultaneous treatment of menopausal disorders and the metabolic syndrome. Menopause 2008,15(6):1120-1131. 10.1097/gme.0b013e31817062ce
28. Medjakovic S, Mueller M, Jungbauer A: Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR. Nutrients 2010,2(3):241-279. 10.3390/nu2030241
29. Carlson S, Peng N, Prasain JK, Wyss JM: Effects of botanical dietary sup-plements on cardiovascular, cognitive, and metabolic function in males and females. Gender. Medicine 2008,5(Suppl. 1):S76-S90.
30. Qiu L, Ye H, Chen L, Hong Y, Zhong F, Zhang T: Red clover extract ameliorates dyslipidemia in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPAR. Phytother Res 2012,26(6):860-864. 10.1002/ptr.3641
31. Kalaiselvan V, Kalaivani M, Vijayakumar A, Sureshkumar K, Venkatesku-mar K: Current knowledge and future direction of research on soy isoflavones as a therapeutic agents. Pharmacogn Rev 2010,4(8):111-117. 10.4103/0973-7847.70900
32. Tsunoo A, Taketomo N, Tsuboi H, Kamijo M, Nemoto A, Sasaki H, Uchida M, Meiji institute of Health Science: Cordyceps Sinensis: Its diverse effects on mammals in vitro and in vivo. Third International Symposium of the Mycological Society of Japan 1995.
33. Yao W, Tian XY, Chen J, Setterberg RB, Lundy MW, Chmielzwski P, Froman CA, Jee WS: Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats. J Musculoskelet Neuronal Interact 2007,7(2):119-130.
34. Diel P, Schulz T, Smolnikar K, Strunck E, Vollmer G, Michna H: Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol 2000, 73:1-10. 10.1016/S0960-0760(00)00051-0
35. Tomita A: Osteoporosis-blood biochemistry. Jpn J Clin Med 1990, 48:2838-2844.
36. Arai K, Komura H, Akikusa T, Iio K, Kishi H, Watanabe G, Taya K: Contributions of endogenous inhibin and estradiol to the regulation of follicle-stimulating hormone and luteinizing hormone secretion in the pregnant rat. Biol Reprod 1997, 56:1482-1489. 10.1095/biolreprod56.6.1482
37. Havill LM, Hale LG, Newman DE, Witte SM, Mahaney MC: Bone ALP and OC reference standards in adult baboons (Papio hamadryas) by sex and age. J Med Primatol 2006, 35:97-105. 10.1111/j.1600-0684.2006.00150.x
38. Ross PD, Knowlton W: Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998, 13:297-302. 10.1359/jbmr.1998.13.2.297
39. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD: Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000, 15:1526-1536. 10.1359/jbmr.2000.15.8.1526
40. Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA: Serum bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study. Osteoporos Int 2000, 11:76-82. 10.1007/s001980050009
41. Polak-Jonkisz D, Zwolinska D: Osteocalcin as a biochemical marker of bone turnover. Nephrology 1998, 4:339-346. 10.1111/j.1440-1797.1998.tb00369.x
42. Burgeson RE: New collagens, new concepts. Annu Rev Cell Biol 1988, 4:552-577.
43. Guerrero R, Diaz Martin MA, Diaz Diego EM, Disla T, Rapado A, De la Piedra C: New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis. Osteoporos Int 1996, 6:297-302.
44. Madyastha PR, Yang S, Ries WL, Key LL Jr: IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production. J. Interferon Cytokine Res 2000, 20:645-652. 10.1089/107999000414826